126 related articles for article (PubMed ID: 30820808)
1. Carnosic Acid Inhibits CXCR3 Ligands Production in IL-27-Stimulated Human Oral Epithelial Cells.
Hosokawa I; Hosokawa Y; Ozaki K; Matsuo T
Inflammation; 2019 Aug; 42(4):1311-1316. PubMed ID: 30820808
[TBL] [Abstract][Full Text] [Related]
2. Honokiol and Magnolol Inhibit CXCL10 and CXCL11 Production in IL-27-Stimulated Human Oral Epithelial Cells.
Hosokawa Y; Hosokawa I; Ozaki K; Matsuo T
Inflammation; 2018 Dec; 41(6):2110-2115. PubMed ID: 30039429
[TBL] [Abstract][Full Text] [Related]
3. IL-27 Modulates Chemokine Production in TNF-α -Stimulated Human Oral Epithelial Cells.
Hosokawa Y; Hosokawa I; Ozaki K; Matsuo T
Cell Physiol Biochem; 2017; 43(3):1198-1206. PubMed ID: 28977795
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
5. Airway smooth muscle CXCR3 ligand production: regulation by JAK-STAT1 and intracellular Ca²⁺.
Tan X; Alrashdan YA; Alkhouri H; Oliver BG; Armour CL; Hughes JM
Am J Physiol Lung Cell Mol Physiol; 2013 Jun; 304(11):L790-802. PubMed ID: 23564506
[TBL] [Abstract][Full Text] [Related]
6. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
[TBL] [Abstract][Full Text] [Related]
7. IL-29 Enhances CXCL10 Production in TNF-α-stimulated Human Oral Epithelial Cells.
Hosokawa Y; Hosokawa I; Shindo S; Ozaki K; Matsuo T
Immunol Invest; 2017 Aug; 46(6):615-624. PubMed ID: 28753407
[TBL] [Abstract][Full Text] [Related]
8. Carnosic acid inhibits inflammatory cytokines production in human periodontal ligament cells.
Hosokawa I; Hosokawa Y; Ozaki K; Matsuo T
Immunopharmacol Immunotoxicol; 2020 Aug; 42(4):373-378. PubMed ID: 32538208
[TBL] [Abstract][Full Text] [Related]
9. The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate G alpha i-independent signaling and actin responses in human intestinal myofibroblasts.
Kouroumalis A; Nibbs RJ; Aptel H; Wright KL; Kolios G; Ward SG
J Immunol; 2005 Oct; 175(8):5403-11. PubMed ID: 16210647
[TBL] [Abstract][Full Text] [Related]
10. CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
Zhang C; Li Z; Xu L; Che X; Wen T; Fan Y; Li C; Wang S; Cheng Y; Wang X; Qu X; Liu Y
BMC Cancer; 2018 Apr; 18(1):462. PubMed ID: 29690901
[TBL] [Abstract][Full Text] [Related]
11. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist.
Heise CE; Pahuja A; Hudson SC; Mistry MS; Putnam AL; Gross MM; Gottlieb PA; Wade WS; Kiankarimi M; Schwarz D; Crowe P; Zlotnik A; Alleva DG
J Pharmacol Exp Ther; 2005 Jun; 313(3):1263-71. PubMed ID: 15761110
[TBL] [Abstract][Full Text] [Related]
13. The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis.
Ueno A; Yamamura M; Iwahashi M; Okamoto A; Aita T; Ogawa N; Makino H
Rheumatol Int; 2005 Jun; 25(5):361-7. PubMed ID: 15004722
[TBL] [Abstract][Full Text] [Related]
14. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Shimizu T; Tada Y; Watanabe S
Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
[TBL] [Abstract][Full Text] [Related]
15. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
16. Expression and agonist responsiveness of CXCR3 variants in human T lymphocytes.
Korniejewska A; McKnight AJ; Johnson Z; Watson ML; Ward SG
Immunology; 2011 Apr; 132(4):503-15. PubMed ID: 21255008
[TBL] [Abstract][Full Text] [Related]
17. The role of IkappaB kinase 2, but not activation of NF-kappaB, in the release of CXCR3 ligands from IFN-gamma-stimulated human bronchial epithelial cells.
Tudhope SJ; Catley MC; Fenwick PS; Russell RE; Rumsey WL; Newton R; Barnes PJ; Donnelly LE
J Immunol; 2007 Nov; 179(9):6237-45. PubMed ID: 17947699
[TBL] [Abstract][Full Text] [Related]
18. Optic neuritis: chemokine receptor CXCR3 and its ligands.
Sørensen TL; Roed H; Sellebjerg F
Br J Ophthalmol; 2004 Sep; 88(9):1146-8. PubMed ID: 15317705
[TBL] [Abstract][Full Text] [Related]
19. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration.
Koper OM; Kamińska J; Sawicki K; Kemona H
Adv Clin Exp Med; 2018 Jun; 27(6):849-856. PubMed ID: 29893515
[TBL] [Abstract][Full Text] [Related]
20. 6-(Methylsulfinyl) Hexyl Isothiocyanate Inhibits IL-6 and CXCL10 Production in TNF-α-Stimulated Human Oral Epithelial Cells.
Shimoyama M; Hosokawa Y; Hosokawa I; Ozaki K; Hosaka K
Curr Issues Mol Biol; 2022 Jun; 44(7):2915-2922. PubMed ID: 35877425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
